Cholera Vaccine Development: Progress, Efficacy, and Public Health Strategies

Abstract

Cholera poses a significant public health challenge, particularly in regions prone to outbreaks. Vaccination plays a critical role in preventing cholera, offering a powerful strategy to mitigate its impact. The paper focuses on the progress and efficacy of cholera vaccine development. The paper found that the cholera vaccine landscape features diverse formulations, including Dukoral®, Shanchol®, and Euvichol®, each having distinct advantages and limitations. While substantial progress has been made in vaccine development, ongoing research is essential to address existing barriers such as distribution challenges, public hesitancy, and limited access to healthcare. Therefore, effective public health strategies should prioritize high-risk populations and integrate vaccination efforts with improved sanitation and water, sanitation, and hygiene (WASH) programmes. Additionally, fostering community engagement through education and local leadership is crucial to overcoming vaccine hesitancy, which is influenced by misinformation and cultural beliefs. Collaboration among public health authorities, researchers, and communities is vital for enhancing vaccine uptake and achieving cholera elimination goals. As challenges evolve, the adaptability of vaccination strategies will be paramount in safeguarding community health and preventing future outbreaks.